Effectiveness of the pandemic influenza A/H1N1 2009 monovalent vaccine in Korea

Vaccine

Volumn 29, Issue 7, 2011, Pages 1395-1398

  Song, Joon Young ^a   Cheong, Hee Jin ^a   Heo, Jung Yeon ^a   Noh, Ji Yun ^a   Choi, Won Suk ^a   Park, Dae Won ^a   Lee, Jacob ^b   Jeong, Hye Won ^c   Kee, Sae Yoon ^d   Kim, Woo Joo ^a  

^a Korea University College of Medicine   (South Korea)

^b Hallym University College of Medicine   (South Korea)

^c Chungbuk National University College of Medicine   (South Korea)

^d Konkuk University School of Medicine   (South Korea)

Author keywords

2009 H1N1; Effectiveness; Influenza; Vaccination

Indexed keywords

MIFAMURTIDE; SWINE INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; PANDEMIC INFLUENZA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; VACCINATION;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE FACILITIES; CASE-CONTROL STUDIES; CHILD; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; REPUBLIC OF KOREA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79151474497     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.12.050     Document Type: Article

References (12)

1. World Health Organization. DG Statement following the meeting of the Emergency Committee [cited 09.09.09]. Available from:; 2009 [accessed 11.06.09]. http://www.who.int/csr/disease/swineflu/4th_meeting_ihr/en/index.html.
2. World Health Organization New influenza A (H1N1) virus: global epidemiological situation. Wkly Epidemiol Rec 2009, 84(June):249-257.
3. Korean Centers for Diseases Control and Prevention Korean influenza surveillance report (KISS), 2008-2009 (Korean) 2009, Korean Centers for Diseases Control and Prevention, Seoul.
4. Cheong H.J., Song J.Y., Heo J.Y., Noh J.Y., Choi W.S., Park D.W., et al. Immunogenicity and safety of Influenza A (H1N1) 2009 monovalent inactivated split vaccine in Korea. Vaccine 2011, 29(3):523-527.
5. Belongia E.A., Kieke B.A., Donahue J.G., Greenlee R.T., Balish A., Foust A., et al. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. J Infect Dis 2009, 199(January (2)):159-167.
6. Korean Centers for Diseases Control and Prevention Current status of selected infectious diseases. Public Health Weekly Report 2009, 2(52):886.
7. Kissling E., Valenciano M., Cohen J., Oroszi B., Barret A., Rizzo C., et al. Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-10: results of I-MOVE multicentre case-control study [abstract]. Options for the control of influenza VII, vol. 898 2010, 79.
8. Shay D., Belongia E., Monto A., Treanor J., Talbot H., Gargiullo P., et al. Effectiveness of U.S. influenza A (H1N1) 2009 monovalent vaccines in preventing healthcare visits associated with RT-PCR-confirmed 2009 H1N1 infections [abstract]. Options for the control of influenza VII, vol. 576 2010, 392.
9. Hancock K., Veguilla V., Lu X., Zhong W., Butler E.N., Sun H., et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009, 361(20):1945-1952.
10. Miller E., Hoschler K., Hardelid P., Stanford E., Andrews N., Zambon M. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 2010, 375(9720):1100-1108.
11. Centers for Disease Control and Prevention (CDC) Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep 2009, 58(19):521-524.
12. Cowling B., Ng S., Cheng C., Wai W., Fang V., Chan K., et al. The effectiveness of seasonal influenza vaccine in preventing pandemic and seasonal influenza infection: a randomized controlled trial [abstract]. Options for the control of influenza VII, vol. 899 2010, 79-80.